| HOME >> MEDICINE >> TECHNOLOGY |
3,885,784General and administrative expenses
1,102,320
1,165,1834,376,554
4,499,521Research and development expenses
345,241
335,8941,292,225
1,431,627Total operating expenses
2,859,313
2,686,48010,700,610
9,816,932Operating income (loss) from continuing operations
200,274
(552,488)(1,489,736)
(2,730,549)Total other income
136,768
112,185686,189
689,878Income (loss) from continuing operations before income taxes
337,042
(440,303)(803,547)
(2,040,671)Income tax expense (benefit)
93,353
18,116(194,782)
64,216Net income (loss) from continuing operations
243,689
(458,419)(608,765)
(2,104,887)Discontinued operations:Net income (loss) from discontinued operations, net of income tax expense(benefit) of $(185,336), $0, $(89,236) and $0
201,124
(990,337)(445,987)
(1,429,359)Gain from sale of discontinued operations, net of income tax expense of $0, $0, $284,337 and $0
-1,421,077
-Net income (loss) from discontinued operations
201,124
(990,337)975,090
(1,429,359)Net income (loss)
$444,813
($1,448,756)$366,325
($3,534,246)Net income (loss) per share from continuing operations-Basic
$0.03
($0.07)($0.09)
($0.30)Net income (loss) per share from discontinued operations-Basic
0.03
(0.14)0.14
(0.20)Net income (loss) per share-Basic
$0.06
($0.21)$0.05
($0.50)Net income (loss) per share from continuing operations-Diluted
$0.03
($0.07)($0.09)
($0.30)Net income (loss) per share from discontinued operations-Diluted
0.03
(0.14)0.14
(0.20)Net income (loss) per share-Diluted
$0.06
($0.21)$0.05
'/>"/>
| SOURCE Misonix, Inc. Copyright©2012 PR Newswire. All rights reserved |